Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galapagos NV (NASDAQ:GLPG)

75.08
Delayed Data
As of Jun 27
 -1.28 / -1.68%
Today’s Change
49.43
Today|||52-Week Range
94.88
+16.97%
Year-to-Date
No recent news for Galapagos NV.

Today’s Trading

Previous close76.36
Today’s open76.42
Day’s range75.05 - 76.82
Volume158,608
Average volume (3 months)183,456
Market cap$3.5B
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)-77.90%
Revenue growth (last year)+227.41%
P/E ratio--
Price/Sales21.24
Price/Book4.41

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-1.37-4.72%
ICPTIntercept Pharmaceut...-8.30-6.37%
PTLAPortola Pharmaceutic...-2.50-4.39%
PBYIPuma Biotechnology I...-2.90-3.30%
Data as of 06/27/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$143.0M
Annual profit (last year)$59.6M
Net profit margin41.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts